NRDC licences Anti-Arthritis Drug developed by CSIR-NEIST and CCRAS to Kudos Laboratories India

New delhi . License Agreements for commercialization of Anti-Arthritis Drugs (Ointment and Tablets) an ayurvedic formulation to get victory over Joint Pain developed by CSIR-NEIST, Jorhat (for ointment) under Ministry of Science and Technology, Govt. of India  and Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi (for the tablets), apex organization for research in Ayurveda in India under the Ministry of AYUSH, Govt. of India were signed  and exchanged between Dr. H. Purushotham Chairman & Managing Director, National Research Development Corporation, an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi (NRDC) and Shri Karan Goomar, Proprietor,  M/s Kudos Labortories India, New Delhi at NRDC Office in the presence of Sh. Gian Chand Goomar,  Dr. Priyanka & other Kudos officials and Senior Executives of NRDC were also present during signing ceremony. On this occasion Dr. H. Purushotham explained the benefits of the drugs.

The ointment as well as the tablets are clinically tested and prepared by highest quality natural botanical extracts and there would be no side effects. It is cost effective and to be used by those people who are suffering from Joint Pains. 

Kudos is the first licensee for the above two innovative technologies. Now Kudos Labortories India could commcercialize this product under their trade name with due acknowledgement to CSIE-NEIST and CCRAS, Ministry of AYUSH, Government of India.